APA (7th ed.) Citation

Toh, T. B., Thng, D. K. H., Bolem, N., Vellayappan, B. A., Tan, B. W. Q., Shen, Y., . . . Wong, A. L. A. (2024). Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol. PLoS ONE, 19(7), 1. https://doi.org/10.1371/journal.pone.0307818

Chicago Style (17th ed.) Citation

Toh, Tan Boon, et al. "Evaluation of Ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma: An Interventional, Non-randomized, Open-label Trial Protocol." PLoS ONE 19, no. 7 (2024): 1. https://doi.org/10.1371/journal.pone.0307818.

MLA (9th ed.) Citation

Toh, Tan Boon, et al. "Evaluation of Ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma: An Interventional, Non-randomized, Open-label Trial Protocol." PLoS ONE, vol. 19, no. 7, 2024, p. 1, https://doi.org/10.1371/journal.pone.0307818.